Cath Lab

The cardiac catheterization laboratory is used for diagnostic angiograms and percutaneous coronary interventions (PCI). Cath labs have also seen expanding use in recent years for transcatheter structural heart procedures. Some hospitals also share these labs with other subspecialties for catheter-based procedures in electrophysiology (EP), interventional radiology, peripheral artery disease (PAD), carotid and neuro interventional procedures and vascular surgery.

Medical device company raises $87M to study new-look scaffolds for BTK PAD
R3 Vascular also announced that Christopher M. Owens, a veteran of the medical device industry, is its new president and CEO.
Radial vs. femoral access during PCI: Real-world data show proof of a ‘sea change’ in cardiology
The use of radial access during PCI procedures is increasing throughout the United States, and new data presented at the SCAI's annual meeting suggest that could be beneficial for patients.
FDA approves Abbott’s resorbable stent for BTK arteries
The bioresorbable stent, examined at length for the LIFE-BTK clinical trial, stays in place for up to three years before completely dissolving.
FDA clears new catheter for peripheral blood clots
The new-look catheter came out of a medical device incubator started by entrepreneur Eitan Konstantino, PhD, who has years of experience in the vascular space.
Cardiologists make history, perform first-ever transcaval TAVR for pure aortic regurgitation
The 65-year-old male patient presented with a long medical history and many comorbidities, making surgery too risky.

Robert Yeh, MD, explains the details of the AGENT IDE trial clinical trial results for the Agent drug-coated balloon vs plain angioplasty for in-stent restenosis at TCT 2023. #TCT #TCT2023 #DCB

Coronary drug-coated balloon superior to standard of care for in-stent restenosis

Robert Yeh, MD, detailed the importance of the pivotal AGENT IDE trial, which focused on the use of a paclitaxel-coated balloon to treat in-stent restenosis.

October 31, 2023

Ziad Ali, MD, explains the ILUMIEN IV trial results for OCT Vs. Angiography.

ILUMIEN IV: OCT adds value over angiography alone, fails to improve outcomes

Ziad Ali, MD, discusses the mixed results of the ILUMIEN IV trial comparing OCT vs angiography alone.

October 23, 2023

Radial access shows potential to ‘revolutionize’ care for peripheral artery disease

Radial access provides interventional cardiologists with a safe, effective alternative to femoral access during peripheral artery interventions.

October 20, 2023

Ken Rosenfield, MD, Mass General Hospital, explains the impact wider CMS reimbursement for carotid artery stenting will have on patient stroke care and interventional cardiology. CAS

Q&A: Ken Rosenfield explains the impact of new reimbursement coverage for carotid stenting

Ken Rosenfield, MD, helped spearhead the recent Medicare policy change that made carotid stenting procedures available to more patients.

October 20, 2023

An interactive diagram for the carotids and arteries of the brain for interventional reporting shown by Fujifilm at HIMSS 2023. Photo by Dave Fornell

CMS changes coverage policy for carotid stenting to make it more widely available

A group of interventional cardiologists, neurologists and vascular surgeons successfully petitioned Medicare to change its coverage determination for carotid stenting procedures.

October 18, 2023

Allia IGS Pulse, GE Healthcare's updated image-guided system for cardiac imaging, gained FDA clearance

FDA clears GE Healthcare’s new image-guided system for heart patients of all sizes

GE Healthcare's newest cardiac angiography offering will be on display at TCT 2023 in San Francisco.

October 18, 2023

A late-breaking science presentation at the annual TCT interventional cardiology meeting.

Late-breaking clinical trials at TCT 2023

Here is a list of all the late-breaking clinical trials being presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2023 annual meeting Oct. 23-26, 2023, in San Francisco.

October 17, 2023

ACC President Hadley Wilson, MD, explained the impact of 4 key ESC 2023 IVUS and OCT intravascular imaging trials and wht thaey will l;ikely influence PCI guidelines. #ESC ESC23 #ESC2023 #ACC

Intravascular imaging for PCI gets a big boost from recent studies

ACC President Hadley Wilson, MD, explains the big impact four late-breaking studies on intravascular imaging may have on revising PCI guidelines.

October 16, 2023

Cath Lab

Medical device company raises $87M to study new-look scaffolds for BTK PAD

Radial vs. femoral access during PCI: Real-world data show proof of a ‘sea change’ in cardiology

FDA approves Abbott’s resorbable stent for BTK arteries

FDA clears new catheter for peripheral blood clots

Cardiologists make history, perform first-ever transcaval TAVR for pure aortic regurgitation